A systematic review of population screening for fragile X syndrome

被引:63
|
作者
Hill, Melissa K. [1 ,2 ]
Archibald, Alison D. [1 ,3 ]
Couns, Grad Dip Genet [1 ,3 ]
Cohen, Jonathan [4 ,5 ]
Metcalfe, Sylvia A. [1 ,3 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
[2] Hosp Children NHS Trust, Inst Child Hlth & Great Ormond St, London, England
[3] Univ Melbourne, Dept Paediat, Melbourne, Australia
[4] Fragile X Alliance Inc, Melbourne, Australia
[5] Monash Univ, Dept Gen Pract, Melbourne, Australia
基金
英国医学研究理事会;
关键词
attitudes; carrier screening; fragile X syndrome; newborn screening; psychosocial; POLYMERASE-CHAIN-REACTION; CGG REPEAT; MENTAL-RETARDATION; NONPREGNANT WOMEN; EXPANDED ALLELES; PREGNANT-WOMEN; NEWBORN MALES; BLOOD SPOTS; FMR1; GENE; ATTITUDES;
D O I
10.1097/GIM.0b013e3181e38fb6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To conduct a systematic review of literature regarding population-based screening for fragile X syndrome in newborns and women of reproductive age, either before or during pregnancy. Methods: Seven electronic databases were searched for English language studies published between January 1991 and November 2009. Data extraction was performed for all included studies. Results were synthesized using a narrative approach. Results: One article that examined offering newborn screening for fragile X syndrome and 10 that examined the offer of fragile X syndrome screening to women of reproductive age were identified. Two of these articles also addressed psychosocial aspects of population screening for fragile X syndrome such as attitudes to screening and experiences of screening, and a further nine addressed these issues alone. Studies exploring psychosocial issues demonstrated challenges for counseling arising from a lack of awareness or personal experience with fragile X syndrome in the general population. Conclusions: Targeted counseling and educational strategies will be essential to support women from the general population. It is crucial that future studies offering screening for fragile X syndrome explore a range of psychosocial aspects in addition to looking at uptake of testing and mutation frequency. Genet Med 2010: 12(7): 396-410.
引用
收藏
页码:396 / 410
页数:15
相关论文
共 50 条
  • [1] POPULATION SCREENING FOR FRAGILE-X SYNDROME
    BUNDEY, S
    NORMAN, E
    LANCET, 1993, 341 (8847): : 770 - 770
  • [2] Commentary on population screening for fragile X syndrome
    Coffee, Bradford
    GENETICS IN MEDICINE, 2010, 12 (07) : 411 - 412
  • [3] Executive Function in Fragile X Syndrome: A Systematic Review
    Schmitt, Lauren M.
    Shaffer, Rebecca C.
    Hessl, David
    Erickson, Craig
    BRAIN SCIENCES, 2019, 9 (01)
  • [4] Systematic review of pharmacological treatments in fragile X syndrome
    Rueda, Jose-Ramon
    Ballesteros, Javier
    Tejada, Maria-Isabel
    BMC NEUROLOGY, 2009, 9 : 53
  • [5] Systematic review of pharmacological treatments in fragile X syndrome
    Jose-Ramon Rueda
    Javier Ballesteros
    Maria-Isabel Tejada
    BMC Neurology, 9 (1)
  • [6] Economic evaluation of prenatal population screening for fragile X syndrome
    Hollingsworth, B
    Harris, A
    COMMUNITY GENETICS, 2005, 8 (02) : 68 - 72
  • [7] POPULATION SCREENING FOR FRAGILE-X
    TURNER, G
    ROBINSON, H
    LAING, S
    VANDENBERK, M
    COLLEY, A
    GODDARD, A
    SHERMAN, S
    PARTINGTON, M
    LANCET, 1992, 339 (8803): : 1210 - 1213
  • [8] Fragile X population carrier screening
    Metcalfe, Sylvia A.
    Delatycki, Martin B.
    Cohen, Jonathan
    Archibald, Alison D.
    Emery, Jon D.
    GENETICS IN MEDICINE, 2018, 20 (09) : 1091 - 1092
  • [9] Fragile X population carrier screening
    Metcalfe, Sylvia A.
    Archibald, Alison D.
    Couns, Grad Dip Genet
    GENETICS IN MEDICINE, 2012, 14 (03) : 350 - 350
  • [10] Newborn Screening for Fragile X Syndrome
    Tassone, Flora
    JAMA NEUROLOGY, 2014, 71 (03) : 355 - 359